SHADI EID MOHAMMAD HAMDAN
Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology MARINETTE, WI NPI 1801088992
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology WI PFIZER INC. All categories
General Payments — all program years on this page
$3,376.28
- Category: General Payments
- Program years: PY2020–2024
- Record count: 143
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,589.41 across 67 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,589.41 | 67 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $210.19 | 10 |
| Alexion Pharmaceuticals, Inc. | $137.23 | 3 |
| Merck Sharp & Dohme Corporation | $130.65 | 6 |
| Takeda Pharmaceuticals U.S.A., Inc. | $120.63 | 4 |
| Gilead Sciences, Inc. | $116.94 | 5 |
| Genentech USA, Inc. | $112.84 | 5 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $65.07 | 3 |
| E.R. Squibb & Sons, L.L.C. | $58.15 | 3 |
| Daiichi Sankyo Inc. | $52.55 | 2 |
| Lilly USA, LLC | $45.96 | 2 |
| Tempus AI, Inc | $45.17 | 2 |
| ABBVIE INC. | $44.96 | 2 |
| GlaxoSmithKline, LLC. | $43.57 | 2 |
| Acerta Pharma LLC | $42.67 | 2 |
| Mirati Therapeutics, Inc. | $40.27 | 2 |
| Janssen Biotech, Inc. | $34.04 | 2 |
| TerSera Therapeutics LLC | $31.90 | 1 |
| EISAI INC. | $29.47 | 1 |
| Ipsen Biopharmaceuticals, Inc | $28.84 | 1 |
| EMD Serono, Inc. | $27.47 | 1 |
| Azurity Pharmaceuticals, Inc. | $25.21 | 1 |
| Pharmacosmos Therapeutics Inc. | $24.46 | 1 |
| Coherus Biosciences Inc. | $23.66 | 1 |
| Telix Pharmaceuticals | $23.05 | 1 |
| Blueprint Medicines Corporation | $22.68 | 1 |
| SOBI, INC | $19.69 | 1 |
| BTG INTERNATIONAL, INC. | $18.20 | 1 |
| Novocure Inc. | $13.89 | 1 |
By program year
Records — PY2024 (67)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.